Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Micro Penny Stocks, Penny Stocks $0.10 & Under » MSITF - Que Pasa?

 - UBBFriend: Email this page to someone!    
Author Topic: MSITF - Que Pasa?
shadow
Member


Rate Member
Icon 5 posted      Profile for shadow     Send New Private Message       Edit/Delete Post   Reply With Quote 
MSITF - Continues to post good PR. Things
appear to be going well with the company.

I have contacted the company (4) times
speaking to Robert Talbot 2x. On each
ocassion he told me that financial information would be forthcoming (in days)
and be posted. (Thus far nada)

I tried calling him yesterday and just got
voicemail. Tried another number and left a message.

I am truly trying to figure out what is up
with this company. Any thoughts would be
greatly appreciated.

It looks to have business and a corner on
the market in some areas.

This looks on the surface to be an awesome
play. GMED with much less going for it
has gone up significantly...

What are your thoughts?


EDMONTON, Alberta, Apr 22, 2004 /PRNewswire-FirstCall via COMTEX/ -- Medical Services International Inc. (Pinksheets: MSITF) wishes to announce that interest in the VScan Dengue Fever kit has increased dramatically. The cases of Dengue Fever are increasing significantly in the Southern United States, Mexico, Central America, the Caribbean and Southeast Asia. The Company has shipped kits to three countries to date and will ship to another 4 before the end of April. The VScan Dengue Fever test kit has an accuracy of 99% in under 20 minutes. The Company licensed the patented reagent on an exclusive basis for certain areas from the United States Naval Research Center for a period of 10 years and combined the reagents with our existing proven technology used in the VScan rapid test kits. The areas in which the company has the exclusive license are the areas where there has been an significant increase in Dengue Fever. The Company will have virtually no competition in these areas. It is reasonable to expect to sell in excess of 300 000 Dengue kits this year which will generate sales of $1,200,000 USD.

Dengue Fever is a mosquito born disease characterized by a rapid onset of fever that may last from 5 to 7 days. After effects of Dengue Fever can last for 6 to 8 months without early detection and treatment. The most severe form is Hemorrhagic Dengue Fever may lead to circulatory failure and death (12%). Dengue can be effectively treated through early diagnosis using fluid replacement therapy. Currently there are so few laboratories available that are able to test for Dengue Fever that it is taking 3 to 4 weeks to get results. By then, the patient can be severely incapacitated or dead. Standard recovery time for the mildest form of Dengue Fever without immediate fluid replacement therapy is 4 to 6 months. The VScan test kit for Dengue Fever detects the virus in its very early stages in under 20 minutes and with immediate fluid replacement therapy the effects are minimal and recovery is very fast. Early detection of the Dengue Virus so the fluid replacement therapy can be used prevents the collapse of the circulatory system.

About VScan

The VScan rapid test kit is a single use, easy to use, test for screening of HIV 1&2 and subgroup O, Hepatitis B&C, Tuberculosis, Dengue Fever and West Nile. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or Bill Whitehead Jr. at (416) 822 5883 or www.medicalservicesintl.com .

NOTE: Certain statements in the press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.

SOURCE Medical Services International Inc.

Robert Talbot, +1-780-430-6363 or Bill Whitehead Jr.,
+1-416-822-5883, both of Medical Services International Inc.
http://www.medicalservicesintl.com


Copyright (C) 2004 PR Newswire. All rights reserved


Posts: 172 | From: Virginia | Registered: Nov 2003  |  IP: Logged | Report this post to a Moderator
will
Member


Icon 1 posted      Profile for will     Send New Private Message       Edit/Delete Post   Reply With Quote 
Look here ---> http://www.allstocks.com/stockmessageboard/ubb/Forum8/HTML/005607.html
Posts: 4893 | From: Burbank IL USA | Registered: Feb 2004  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share